Alkem Lab

62
Hold
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
5,723.60
111.95 (1.99%)
BSENSE

Dec 05

BSE+NSE Vol: 27.58 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
12,964.00
12,667.00
11,599.00
10,634.00
8,865.00
8,344.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
12,964.00
12,667.00
11,599.00
10,634.00
8,865.00
8,344.00
Expenditure (Ex Depriciation)
Stock Adjustments
-190.00
14.00
462.00
-535.00
-333.00
-229.00
Raw Materials Consumed
4,954.00
4,923.00
4,444.00
4,715.00
3,832.00
3,574.00
Power & Fuel Cost
168.00
162.00
163.00
162.00
129.00
130.00
Employee Cost
2,453.00
2,201.00
2,131.00
1,962.00
1,621.00
1,505.00
Operating Expenses
533.00
475.00
441.00
434.00
360.00
372.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,293.00
1,281.00
1,315.00
1,049.00
683.00
836.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
442.00
570.00
274.00
195.00
146.00
180.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
10,452.00
10,422.00
9,989.00
8,581.00
6,922.00
6,870.00
Operating Profit (PBDIT) excl Other Income
2,512.00
2,245.00
1,609.00
2,052.00
1,942.00
1,473.00
Other Income
493.00
310.00
216.00
162.00
233.00
104.00
Operating Profit (PBDIT)
3,005.00
2,556.00
1,825.00
2,215.00
2,175.00
1,577.00
Interest
121.00
112.00
107.00
52.00
58.00
65.00
Profit before Depriciation and Tax
2,884.00
2,443.00
1,718.00
2,163.00
2,116.00
1,512.00
Depreciation
357.00
299.00
310.00
303.00
274.00
252.00
Profit Before Taxation & Exceptional Items
2,527.00
2,144.00
1,407.00
1,859.00
1,842.00
1,259.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
2,527.00
2,023.00
1,304.00
1,844.00
1,842.00
1,259.00
Provision for Tax
311.00
211.00
297.00
163.00
224.00
110.00
Profit After Tax
2,216.00
1,811.00
1,006.00
1,680.00
1,617.00
1,149.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
8,309.00
7,051.00
6,593.00
5,366.00
4,116.00
3,422.00
Profit Available for appropriations
10,475.00
8,847.00
7,578.00
7,012.00
5,701.00
4,549.00
Appropriations
10,475.00
8,847.00
7,578.00
7,012.00
5,701.00
4,549.00
Equity Dividend (%)
2,250.00%
2,000.00%
2,500.00%
1,700.00%
1,500.00%
1,250.00%
Earnings Per Share
181.11
150.19
82.31
137.63
132.57
94.26
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.34% vs 9.21% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 11.88% vs 39.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 8.26% vs 4.70% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 22.33% vs 79.92% in Mar 2024

Compare Profit and Loss Results of Alkem Lab
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
12,964.00
29,001.00
-16,037.00
-55.30%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
12,964.00
29,001.00
-16,037.00
-55.30%
Expenditure (Ex Depriciation)
Stock Adjustments
-190.00
-946.00
756.00
79.92%
Raw Materials Consumed
4,954.00
13,549.00
-8,595.00
-63.44%
Power & Fuel Cost
168.00
826.00
-658.00
-79.66%
Employee Cost
2,453.00
3,922.00
-1,469.00
-37.46%
Operating Expenses
533.00
1,142.00
-609.00
-53.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,293.00
1,684.00
-391.00
-23.22%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
442.00
691.00
-249.00
-36.03%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
10,452.00
23,158.00
-12,706.00
-54.87%
Operating Profit (PBDIT) excl Other Income
2,512.00
5,843.00
-3,331.00
-57.01%
Other Income
493.00
557.00
-64.00
-11.49%
Operating Profit (PBDIT)
3,005.00
6,400.00
-3,395.00
-53.05%
Interest
121.00
289.00
-168.00
-58.13%
Profit before Depriciation and Tax
2,884.00
6,110.00
-3,226.00
-52.80%
Depreciation
357.00
1,521.00
-1,164.00
-76.53%
Profit Before Taxation & Exceptional Items
2,527.00
4,589.00
-2,062.00
-44.93%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,527.00
4,379.00
-1,852.00
-42.29%
Provision for Tax
311.00
1,211.00
-900.00
-74.32%
Profit After Tax
2,216.00
3,186.00
-970.00
-30.45%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
8,309.00
23,910.00
-15,601.00
-65.25%
Profit Available for appropriations
10,475.00
27,083.00
-16,608.00
-61.32%
Appropriations
10,475.00
27,083.00
-16,608.00
-61.32%
Equity Dividend (%)
2250%
450%
1,800.00
Earnings Per Share
181.11
54.16
126.95
234.40%
Profit And Loss - Net Sales
Net Sales 12,964.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.34% vs 9.21% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,512.15 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.88% vs 39.52% in Mar 2024

Profit And Loss - Interest
Interest 121.70 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.26% vs 4.70% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 2,216.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 22.33% vs 79.92% in Mar 2024